Rilpivirine (E) Nitrile Impurity with CAS No: 500292-94-4 is an impurity standard of Rilpivirine. Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infection. Structurally, rilpivirine is a diarylpyrimidine derivative. It functions by inhibiting the reverse transcriptase enzyme of the human immunodeficiency virus (HIV), thereby impeding the replication of the virus within human cells. Rilpivirine is often prescribed as part of combination antiretroviral therapy (ART) to suppress viral replication and manage HIV infection. Its use is typically reserved for individuals with no prior history of antiretroviral treatment and with low viral loads. Buy high quality Rilpivirine (E) Nitrile Impurity from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Rilpivirine (E) Nitrile Impurity
Rilpivirine (E) Nitrile Impurity
CAT. No.
CP-R13002
CAS. No.
500292-94-4
Mol. F.
C11H12N2
Mol. Wt.
172.23
Stock Status
Custom Synthesis
Rel. Cas No
661489-23-2(HClsalt)
Category:
Impurity Standards
Synonyms:
NA
Chemical Name:
(E)-3-(4-amino-3,5-dimethylphenyl)acrylonitrile
Request for Quotation : Rilpivirine (E) Nitrile Impurity
Search by Keywords - Buy 500292-94-4 | Purchase 500292-94-4 | Order 500292-94-4 | Enquire 500292-94-4 | Price of 500292-94-4 | 500292-94-4 Cost | 500292-94-4 Supplier | 500292-94-4 Distributor | 500292-94-4 Manufacturer | 500292-94-4 Exporter | Rilpivirine (E) Nitrile Impurity for Method Validation | Rilpivirine (E) Nitrile Impurity for ANDA Filing | Rilpivirine (E) Nitrile Impurity for Forced Degradation Studies | Rilpivirine (E) Nitrile Impurity Identification Standards | Rilpivirine (E) Nitrile Impurity for DMF Filing | Rilpivirine
We have received your request successfully. Thank you for your interest in our product line. To
provide you with a Quotation, Our Sales team will contact you shortly.
Chemicea Pharmaceuticals Pvt. Ltd.
Thank You
You will receive blog content, featuring scientific research and exclusive promotions.